Drug Patent Profile
Vancomycin
At a glance
- Drug Originator Eli Lilly and Company
- Drug Licenced by Shionogi
- Drug Class Antibacterials; Glycopeptides; Peptide antibiotics
- Mechanism of Action Cell wall inhibitors
- USA Patent Applicants FRESENIUS KABI USA; HIKMA; HOSPIRA; MYLAN LABS LTD; MEDIMETRIKS PHARMS; HOSPIRA INC; PAI HOLDINGS PHARM; STRIDES PHARMA; WATSON LABS; SANDOZ; LUPIN LTD; XELLIA PHARMS APS; SAGENT PHARMS; SANDOZ INC; TEVA PHARMS USA; AVET LIFESCIENCES; GLAND PHARMA LTD; EUGIA PHARMA; HIKMA PHARMS; ZHEJIANG NOVUS PHARM; ORIENT PHARMA CO LTD; SLATE RUN PHARMA; KNACK; ALKEM LABS LTD; MEITHEAL; AMNEAL; ASPIRO
- USA Patents 6
- NDAs 51
- International Patents 47
- Patent Applications 2,323

Disclaimer
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.